Global Vaginal Anti Infectives Market Research Report 2026(Status and Outlook)
Vaginal anti-infectives are the type of agents that are used for the killing or supressing the infection of vagina caused by numerous bacteria, virus, fungi or micro-organism. These bacteria and others invade the host by means of its replication or releasing several toxins into the host. "Yeast" infections, tyrichomoniasis vaginitis, bacterial vaginosis, chlamydia vaginitis, and viral vaginitis are the major forms of vaginitis. About one third women all over the world experience indications of vaginitis at some point in their lifetime. Women are highly prone to vaginitis during the reproductive age; a change in the balance of bacteria and yeast present in vagina can lead to vaginitis.
The global Vaginal Anti Infectives market size was estimated at USD 3364.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Vaginal Anti Infectives market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Vaginal Anti Infectives market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Vaginal Anti Infectives market.
Global Vaginal Anti Infectives Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer Inc
Mylan N.V
Novartis AG
Hikma Pharmaceuticals plc
Aurobindo Pharma
AbbVie Inc
Melinta Therapeutics, Inc
Bristol-Myers Squibb Company
GSK plc
Bayer AG
Lupin
Perrigo Company plc
Bayer
Sanofi
Scynexis
Bausch Health Companies Inc
Market Segmentation (by Type)
Oral
Ointment
Market Segmentation (by Application)
Bacterial Vaginitis
Trichomonal Vaginitis
Candida Vaginitis
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Vaginal Anti Infectives Market
Overview of the regional outlook of the Vaginal Anti Infectives Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaginal Anti Infectives Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Vaginal Anti Infectives, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Vaginal Anti Infectives market size was estimated at USD 3364.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Vaginal Anti Infectives market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Vaginal Anti Infectives market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Vaginal Anti Infectives market.
Global Vaginal Anti Infectives Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Pfizer Inc
Mylan N.V
Novartis AG
Hikma Pharmaceuticals plc
Aurobindo Pharma
AbbVie Inc
Melinta Therapeutics, Inc
Bristol-Myers Squibb Company
GSK plc
Bayer AG
Lupin
Perrigo Company plc
Bayer
Sanofi
Scynexis
Bausch Health Companies Inc
Market Segmentation (by Type)
Oral
Ointment
Market Segmentation (by Application)
Bacterial Vaginitis
Trichomonal Vaginitis
Candida Vaginitis
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Vaginal Anti Infectives Market
Overview of the regional outlook of the Vaginal Anti Infectives Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaginal Anti Infectives Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Vaginal Anti Infectives, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Vaginal Anti Infectives
1.2 Key Market Segments
1.2.1 Vaginal Anti Infectives Segment by Type
1.2.2 Vaginal Anti Infectives Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VAGINAL ANTI INFECTIVES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaginal Anti Infectives Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Vaginal Anti Infectives Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VAGINAL ANTI INFECTIVES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Vaginal Anti Infectives Product Life Cycle
3.3 Global Vaginal Anti Infectives Sales by Manufacturers (2020-2025)
3.4 Global Vaginal Anti Infectives Revenue Market Share by Manufacturers (2020-2025)
3.5 Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Vaginal Anti Infectives Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Vaginal Anti Infectives Market Competitive Situation and Trends
3.8.1 Vaginal Anti Infectives Market Concentration Rate
3.8.2 Global 5 and 10 Largest Vaginal Anti Infectives Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VAGINAL ANTI INFECTIVES INDUSTRY CHAIN ANALYSIS
4.1 Vaginal Anti Infectives Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VAGINAL ANTI INFECTIVES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Vaginal Anti Infectives Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Vaginal Anti Infectives Market
5.7 ESG Ratings of Leading Companies
6 VAGINAL ANTI INFECTIVES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaginal Anti Infectives Sales Market Share by Type (2020-2025)
6.3 Global Vaginal Anti Infectives Market Size by Type (2020-2025)
6.4 Global Vaginal Anti Infectives Price by Type (2020-2025)
7 VAGINAL ANTI INFECTIVES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaginal Anti Infectives Market Sales by Application (2020-2025)
7.3 Global Vaginal Anti Infectives Market Size (M USD) by Application (2020-2025)
7.4 Global Vaginal Anti Infectives Sales Growth Rate by Application (2020-2025)
8 VAGINAL ANTI INFECTIVES MARKET SALES BY REGION
8.1 Global Vaginal Anti Infectives Sales by Region
8.1.1 Global Vaginal Anti Infectives Sales by Region
8.1.2 Global Vaginal Anti Infectives Sales Market Share by Region
8.2 Global Vaginal Anti Infectives Market Size by Region
8.2.1 Global Vaginal Anti Infectives Market Size by Region
8.2.2 Global Vaginal Anti Infectives Market Size by Region
8.3 North America
8.3.1 North America Vaginal Anti Infectives Sales by Country
8.3.2 North America Vaginal Anti Infectives Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Vaginal Anti Infectives Sales by Country
8.4.2 Europe Vaginal Anti Infectives Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Vaginal Anti Infectives Sales by Region
8.5.2 Asia Pacific Vaginal Anti Infectives Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Vaginal Anti Infectives Sales by Country
8.6.2 South America Vaginal Anti Infectives Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Vaginal Anti Infectives Sales by Region
8.7.2 Middle East and Africa Vaginal Anti Infectives Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VAGINAL ANTI INFECTIVES MARKET PRODUCTION BY REGION
9.1 Global Production of Vaginal Anti Infectives by Region(2020-2025)
9.2 Global Vaginal Anti Infectives Revenue Market Share by Region (2020-2025)
9.3 Global Vaginal Anti Infectives Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Vaginal Anti Infectives Production
9.4.1 North America Vaginal Anti Infectives Production Growth Rate (2020-2025)
9.4.2 North America Vaginal Anti Infectives Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Vaginal Anti Infectives Production
9.5.1 Europe Vaginal Anti Infectives Production Growth Rate (2020-2025)
9.5.2 Europe Vaginal Anti Infectives Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Vaginal Anti Infectives Production (2020-2025)
9.6.1 Japan Vaginal Anti Infectives Production Growth Rate (2020-2025)
9.6.2 Japan Vaginal Anti Infectives Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Vaginal Anti Infectives Production (2020-2025)
9.7.1 China Vaginal Anti Infectives Production Growth Rate (2020-2025)
9.7.2 China Vaginal Anti Infectives Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer Inc
10.1.1 Pfizer Inc Basic Information
10.1.2 Pfizer Inc Vaginal Anti Infectives Product Overview
10.1.3 Pfizer Inc Vaginal Anti Infectives Product Market Performance
10.1.4 Pfizer Inc Business Overview
10.1.5 Pfizer Inc SWOT Analysis
10.1.6 Pfizer Inc Recent Developments
10.2 Mylan N.V
10.2.1 Mylan N.V Basic Information
10.2.2 Mylan N.V Vaginal Anti Infectives Product Overview
10.2.3 Mylan N.V Vaginal Anti Infectives Product Market Performance
10.2.4 Mylan N.V Business Overview
10.2.5 Mylan N.V SWOT Analysis
10.2.6 Mylan N.V Recent Developments
10.3 Novartis AG
10.3.1 Novartis AG Basic Information
10.3.2 Novartis AG Vaginal Anti Infectives Product Overview
10.3.3 Novartis AG Vaginal Anti Infectives Product Market Performance
10.3.4 Novartis AG Business Overview
10.3.5 Novartis AG SWOT Analysis
10.3.6 Novartis AG Recent Developments
10.4 Hikma Pharmaceuticals plc
10.4.1 Hikma Pharmaceuticals plc Basic Information
10.4.2 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Overview
10.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Market Performance
10.4.4 Hikma Pharmaceuticals plc Business Overview
10.4.5 Hikma Pharmaceuticals plc Recent Developments
10.5 Aurobindo Pharma
10.5.1 Aurobindo Pharma Basic Information
10.5.2 Aurobindo Pharma Vaginal Anti Infectives Product Overview
10.5.3 Aurobindo Pharma Vaginal Anti Infectives Product Market Performance
10.5.4 Aurobindo Pharma Business Overview
10.5.5 Aurobindo Pharma Recent Developments
10.6 AbbVie Inc
10.6.1 AbbVie Inc Basic Information
10.6.2 AbbVie Inc Vaginal Anti Infectives Product Overview
10.6.3 AbbVie Inc Vaginal Anti Infectives Product Market Performance
10.6.4 AbbVie Inc Business Overview
10.6.5 AbbVie Inc Recent Developments
10.7 Melinta Therapeutics, Inc
10.7.1 Melinta Therapeutics, Inc Basic Information
10.7.2 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Overview
10.7.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Market Performance
10.7.4 Melinta Therapeutics, Inc Business Overview
10.7.5 Melinta Therapeutics, Inc Recent Developments
10.8 Bristol-Myers Squibb Company
10.8.1 Bristol-Myers Squibb Company Basic Information
10.8.2 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Overview
10.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Market Performance
10.8.4 Bristol-Myers Squibb Company Business Overview
10.8.5 Bristol-Myers Squibb Company Recent Developments
10.9 GSK plc
10.9.1 GSK plc Basic Information
10.9.2 GSK plc Vaginal Anti Infectives Product Overview
10.9.3 GSK plc Vaginal Anti Infectives Product Market Performance
10.9.4 GSK plc Business Overview
10.9.5 GSK plc Recent Developments
10.10 Bayer AG
10.10.1 Bayer AG Basic Information
10.10.2 Bayer AG Vaginal Anti Infectives Product Overview
10.10.3 Bayer AG Vaginal Anti Infectives Product Market Performance
10.10.4 Bayer AG Business Overview
10.10.5 Bayer AG Recent Developments
10.11 Lupin
10.11.1 Lupin Basic Information
10.11.2 Lupin Vaginal Anti Infectives Product Overview
10.11.3 Lupin Vaginal Anti Infectives Product Market Performance
10.11.4 Lupin Business Overview
10.11.5 Lupin Recent Developments
10.12 Perrigo Company plc
10.12.1 Perrigo Company plc Basic Information
10.12.2 Perrigo Company plc Vaginal Anti Infectives Product Overview
10.12.3 Perrigo Company plc Vaginal Anti Infectives Product Market Performance
10.12.4 Perrigo Company plc Business Overview
10.12.5 Perrigo Company plc Recent Developments
10.13 Bayer
10.13.1 Bayer Basic Information
10.13.2 Bayer Vaginal Anti Infectives Product Overview
10.13.3 Bayer Vaginal Anti Infectives Product Market Performance
10.13.4 Bayer Business Overview
10.13.5 Bayer Recent Developments
10.14 Sanofi
10.14.1 Sanofi Basic Information
10.14.2 Sanofi Vaginal Anti Infectives Product Overview
10.14.3 Sanofi Vaginal Anti Infectives Product Market Performance
10.14.4 Sanofi Business Overview
10.14.5 Sanofi Recent Developments
10.15 Scynexis
10.15.1 Scynexis Basic Information
10.15.2 Scynexis Vaginal Anti Infectives Product Overview
10.15.3 Scynexis Vaginal Anti Infectives Product Market Performance
10.15.4 Scynexis Business Overview
10.15.5 Scynexis Recent Developments
10.16 Bausch Health Companies Inc
10.16.1 Bausch Health Companies Inc Basic Information
10.16.2 Bausch Health Companies Inc Vaginal Anti Infectives Product Overview
10.16.3 Bausch Health Companies Inc Vaginal Anti Infectives Product Market Performance
10.16.4 Bausch Health Companies Inc Business Overview
10.16.5 Bausch Health Companies Inc Recent Developments
11 VAGINAL ANTI INFECTIVES MARKET FORECAST BY REGION
11.1 Global Vaginal Anti Infectives Market Size Forecast
11.2 Global Vaginal Anti Infectives Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Vaginal Anti Infectives Market Size Forecast by Country
11.2.3 Asia Pacific Vaginal Anti Infectives Market Size Forecast by Region
11.2.4 South America Vaginal Anti Infectives Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Vaginal Anti Infectives by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Vaginal Anti Infectives Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Vaginal Anti Infectives by Type (2026-2035)
12.1.2 Global Vaginal Anti Infectives Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Vaginal Anti Infectives by Type (2026-2035)
12.2 Global Vaginal Anti Infectives Market Forecast by Application (2026-2035)
12.2.1 Global Vaginal Anti Infectives Sales (K MT) Forecast by Application
12.2.2 Global Vaginal Anti Infectives Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Vaginal Anti Infectives
1.2 Key Market Segments
1.2.1 Vaginal Anti Infectives Segment by Type
1.2.2 Vaginal Anti Infectives Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VAGINAL ANTI INFECTIVES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaginal Anti Infectives Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Vaginal Anti Infectives Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VAGINAL ANTI INFECTIVES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Vaginal Anti Infectives Product Life Cycle
3.3 Global Vaginal Anti Infectives Sales by Manufacturers (2020-2025)
3.4 Global Vaginal Anti Infectives Revenue Market Share by Manufacturers (2020-2025)
3.5 Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Vaginal Anti Infectives Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Vaginal Anti Infectives Market Competitive Situation and Trends
3.8.1 Vaginal Anti Infectives Market Concentration Rate
3.8.2 Global 5 and 10 Largest Vaginal Anti Infectives Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VAGINAL ANTI INFECTIVES INDUSTRY CHAIN ANALYSIS
4.1 Vaginal Anti Infectives Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VAGINAL ANTI INFECTIVES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Vaginal Anti Infectives Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Vaginal Anti Infectives Market
5.7 ESG Ratings of Leading Companies
6 VAGINAL ANTI INFECTIVES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaginal Anti Infectives Sales Market Share by Type (2020-2025)
6.3 Global Vaginal Anti Infectives Market Size by Type (2020-2025)
6.4 Global Vaginal Anti Infectives Price by Type (2020-2025)
7 VAGINAL ANTI INFECTIVES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaginal Anti Infectives Market Sales by Application (2020-2025)
7.3 Global Vaginal Anti Infectives Market Size (M USD) by Application (2020-2025)
7.4 Global Vaginal Anti Infectives Sales Growth Rate by Application (2020-2025)
8 VAGINAL ANTI INFECTIVES MARKET SALES BY REGION
8.1 Global Vaginal Anti Infectives Sales by Region
8.1.1 Global Vaginal Anti Infectives Sales by Region
8.1.2 Global Vaginal Anti Infectives Sales Market Share by Region
8.2 Global Vaginal Anti Infectives Market Size by Region
8.2.1 Global Vaginal Anti Infectives Market Size by Region
8.2.2 Global Vaginal Anti Infectives Market Size by Region
8.3 North America
8.3.1 North America Vaginal Anti Infectives Sales by Country
8.3.2 North America Vaginal Anti Infectives Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Vaginal Anti Infectives Sales by Country
8.4.2 Europe Vaginal Anti Infectives Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Vaginal Anti Infectives Sales by Region
8.5.2 Asia Pacific Vaginal Anti Infectives Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Vaginal Anti Infectives Sales by Country
8.6.2 South America Vaginal Anti Infectives Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Vaginal Anti Infectives Sales by Region
8.7.2 Middle East and Africa Vaginal Anti Infectives Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VAGINAL ANTI INFECTIVES MARKET PRODUCTION BY REGION
9.1 Global Production of Vaginal Anti Infectives by Region(2020-2025)
9.2 Global Vaginal Anti Infectives Revenue Market Share by Region (2020-2025)
9.3 Global Vaginal Anti Infectives Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Vaginal Anti Infectives Production
9.4.1 North America Vaginal Anti Infectives Production Growth Rate (2020-2025)
9.4.2 North America Vaginal Anti Infectives Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Vaginal Anti Infectives Production
9.5.1 Europe Vaginal Anti Infectives Production Growth Rate (2020-2025)
9.5.2 Europe Vaginal Anti Infectives Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Vaginal Anti Infectives Production (2020-2025)
9.6.1 Japan Vaginal Anti Infectives Production Growth Rate (2020-2025)
9.6.2 Japan Vaginal Anti Infectives Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Vaginal Anti Infectives Production (2020-2025)
9.7.1 China Vaginal Anti Infectives Production Growth Rate (2020-2025)
9.7.2 China Vaginal Anti Infectives Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer Inc
10.1.1 Pfizer Inc Basic Information
10.1.2 Pfizer Inc Vaginal Anti Infectives Product Overview
10.1.3 Pfizer Inc Vaginal Anti Infectives Product Market Performance
10.1.4 Pfizer Inc Business Overview
10.1.5 Pfizer Inc SWOT Analysis
10.1.6 Pfizer Inc Recent Developments
10.2 Mylan N.V
10.2.1 Mylan N.V Basic Information
10.2.2 Mylan N.V Vaginal Anti Infectives Product Overview
10.2.3 Mylan N.V Vaginal Anti Infectives Product Market Performance
10.2.4 Mylan N.V Business Overview
10.2.5 Mylan N.V SWOT Analysis
10.2.6 Mylan N.V Recent Developments
10.3 Novartis AG
10.3.1 Novartis AG Basic Information
10.3.2 Novartis AG Vaginal Anti Infectives Product Overview
10.3.3 Novartis AG Vaginal Anti Infectives Product Market Performance
10.3.4 Novartis AG Business Overview
10.3.5 Novartis AG SWOT Analysis
10.3.6 Novartis AG Recent Developments
10.4 Hikma Pharmaceuticals plc
10.4.1 Hikma Pharmaceuticals plc Basic Information
10.4.2 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Overview
10.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Market Performance
10.4.4 Hikma Pharmaceuticals plc Business Overview
10.4.5 Hikma Pharmaceuticals plc Recent Developments
10.5 Aurobindo Pharma
10.5.1 Aurobindo Pharma Basic Information
10.5.2 Aurobindo Pharma Vaginal Anti Infectives Product Overview
10.5.3 Aurobindo Pharma Vaginal Anti Infectives Product Market Performance
10.5.4 Aurobindo Pharma Business Overview
10.5.5 Aurobindo Pharma Recent Developments
10.6 AbbVie Inc
10.6.1 AbbVie Inc Basic Information
10.6.2 AbbVie Inc Vaginal Anti Infectives Product Overview
10.6.3 AbbVie Inc Vaginal Anti Infectives Product Market Performance
10.6.4 AbbVie Inc Business Overview
10.6.5 AbbVie Inc Recent Developments
10.7 Melinta Therapeutics, Inc
10.7.1 Melinta Therapeutics, Inc Basic Information
10.7.2 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Overview
10.7.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Market Performance
10.7.4 Melinta Therapeutics, Inc Business Overview
10.7.5 Melinta Therapeutics, Inc Recent Developments
10.8 Bristol-Myers Squibb Company
10.8.1 Bristol-Myers Squibb Company Basic Information
10.8.2 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Overview
10.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Market Performance
10.8.4 Bristol-Myers Squibb Company Business Overview
10.8.5 Bristol-Myers Squibb Company Recent Developments
10.9 GSK plc
10.9.1 GSK plc Basic Information
10.9.2 GSK plc Vaginal Anti Infectives Product Overview
10.9.3 GSK plc Vaginal Anti Infectives Product Market Performance
10.9.4 GSK plc Business Overview
10.9.5 GSK plc Recent Developments
10.10 Bayer AG
10.10.1 Bayer AG Basic Information
10.10.2 Bayer AG Vaginal Anti Infectives Product Overview
10.10.3 Bayer AG Vaginal Anti Infectives Product Market Performance
10.10.4 Bayer AG Business Overview
10.10.5 Bayer AG Recent Developments
10.11 Lupin
10.11.1 Lupin Basic Information
10.11.2 Lupin Vaginal Anti Infectives Product Overview
10.11.3 Lupin Vaginal Anti Infectives Product Market Performance
10.11.4 Lupin Business Overview
10.11.5 Lupin Recent Developments
10.12 Perrigo Company plc
10.12.1 Perrigo Company plc Basic Information
10.12.2 Perrigo Company plc Vaginal Anti Infectives Product Overview
10.12.3 Perrigo Company plc Vaginal Anti Infectives Product Market Performance
10.12.4 Perrigo Company plc Business Overview
10.12.5 Perrigo Company plc Recent Developments
10.13 Bayer
10.13.1 Bayer Basic Information
10.13.2 Bayer Vaginal Anti Infectives Product Overview
10.13.3 Bayer Vaginal Anti Infectives Product Market Performance
10.13.4 Bayer Business Overview
10.13.5 Bayer Recent Developments
10.14 Sanofi
10.14.1 Sanofi Basic Information
10.14.2 Sanofi Vaginal Anti Infectives Product Overview
10.14.3 Sanofi Vaginal Anti Infectives Product Market Performance
10.14.4 Sanofi Business Overview
10.14.5 Sanofi Recent Developments
10.15 Scynexis
10.15.1 Scynexis Basic Information
10.15.2 Scynexis Vaginal Anti Infectives Product Overview
10.15.3 Scynexis Vaginal Anti Infectives Product Market Performance
10.15.4 Scynexis Business Overview
10.15.5 Scynexis Recent Developments
10.16 Bausch Health Companies Inc
10.16.1 Bausch Health Companies Inc Basic Information
10.16.2 Bausch Health Companies Inc Vaginal Anti Infectives Product Overview
10.16.3 Bausch Health Companies Inc Vaginal Anti Infectives Product Market Performance
10.16.4 Bausch Health Companies Inc Business Overview
10.16.5 Bausch Health Companies Inc Recent Developments
11 VAGINAL ANTI INFECTIVES MARKET FORECAST BY REGION
11.1 Global Vaginal Anti Infectives Market Size Forecast
11.2 Global Vaginal Anti Infectives Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Vaginal Anti Infectives Market Size Forecast by Country
11.2.3 Asia Pacific Vaginal Anti Infectives Market Size Forecast by Region
11.2.4 South America Vaginal Anti Infectives Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Vaginal Anti Infectives by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Vaginal Anti Infectives Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Vaginal Anti Infectives by Type (2026-2035)
12.1.2 Global Vaginal Anti Infectives Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Vaginal Anti Infectives by Type (2026-2035)
12.2 Global Vaginal Anti Infectives Market Forecast by Application (2026-2035)
12.2.1 Global Vaginal Anti Infectives Sales (K MT) Forecast by Application
12.2.2 Global Vaginal Anti Infectives Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Vaginal Anti Infectives Market Size by Type (M USD)
Table 4. Global Vaginal Anti Infectives Market Size by Application
Table 5. Vaginal Anti Infectives Market Size Comparison by Region (M USD)
Table 6. Global Vaginal Anti Infectives Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Vaginal Anti Infectives Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Vaginal Anti Infectives Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Vaginal Anti Infectives Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Anti Infectives as of 2025)
Table 11. Global Market Vaginal Anti Infectives Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Vaginal Anti Infectives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Vaginal Anti Infectives Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Vaginal Anti Infectives Sales by Type (K MT)
Table 27. Global Vaginal Anti Infectives Market Size by Type (M USD)
Table 28. Global Vaginal Anti Infectives Sales (K MT) by Type (2020-2025)
Table 29. Global Vaginal Anti Infectives Sales Market Share by Type (2020-2025)
Table 30. Global Vaginal Anti Infectives Market Size (M USD) by Type (2020-2025)
Table 31. Global Vaginal Anti Infectives Market Share by Type (2020-2025)
Table 32. Global Vaginal Anti Infectives Price (USD/KG) by Type (2020-2025)
Table 33. Global Vaginal Anti Infectives Sales (K MT) by Application
Table 34. Global Vaginal Anti Infectives Market Size by Application
Table 35. Global Vaginal Anti Infectives Sales by Application (2020-2025) & (K MT)
Table 36. Global Vaginal Anti Infectives Sales Market Share by Application (2020-2025)
Table 37. Global Vaginal Anti Infectives Market Size by Application (2020-2025) & (M USD)
Table 38. Global Vaginal Anti Infectives Market Share by Application (2020-2025)
Table 39. Global Vaginal Anti Infectives Sales Growth Rate by Application (2020-2025)
Table 40. Global Vaginal Anti Infectives Sales by Region (2020-2025) & (K MT)
Table 41. Global Vaginal Anti Infectives Sales Market Share by Region (2020-2025)
Table 42. Global Vaginal Anti Infectives Market Size by Region (2020-2025) & (M USD)
Table 43. Global Vaginal Anti Infectives Market Size by Region (2020-2025)
Table 44. North America Vaginal Anti Infectives Sales by Country (2020-2025) & (K MT)
Table 45. North America Vaginal Anti Infectives Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Vaginal Anti Infectives Sales by Country (2020-2025) & (K MT)
Table 47. Europe Vaginal Anti Infectives Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Vaginal Anti Infectives Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Vaginal Anti Infectives Market Size by Region (2020-2025) & (M USD)
Table 50. South America Vaginal Anti Infectives Sales by Country (2020-2025) & (K MT)
Table 51. South America Vaginal Anti Infectives Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Vaginal Anti Infectives Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Vaginal Anti Infectives Market Size by Region (2020-2025) & (M USD)
Table 54. Global Vaginal Anti Infectives Production (K MT) by Region(2020-2025)
Table 55. Global Vaginal Anti Infectives Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Vaginal Anti Infectives Revenue Market Share by Region (2020-2025)
Table 57. Global Vaginal Anti Infectives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Vaginal Anti Infectives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Vaginal Anti Infectives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Vaginal Anti Infectives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Vaginal Anti Infectives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Inc Basic Information
Table 63. Pfizer Inc Vaginal Anti Infectives Product Overview
Table 64. Pfizer Inc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Inc Business Overview
Table 66. Pfizer Inc SWOT Analysis
Table 67. Pfizer Inc Recent Developments
Table 68. Mylan N.V Basic Information
Table 69. Mylan N.V Vaginal Anti Infectives Product Overview
Table 70. Mylan N.V Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Mylan N.V Business Overview
Table 72. Mylan N.V SWOT Analysis
Table 73. Mylan N.V Recent Developments
Table 74. Novartis AG Basic Information
Table 75. Novartis AG Vaginal Anti Infectives Product Overview
Table 76. Novartis AG Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Novartis AG Business Overview
Table 78. Novartis AG SWOT Analysis
Table 79. Novartis AG Recent Developments
Table 80. Hikma Pharmaceuticals plc Basic Information
Table 81. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Overview
Table 82. Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Hikma Pharmaceuticals plc Business Overview
Table 84. Hikma Pharmaceuticals plc Recent Developments
Table 85. Aurobindo Pharma Basic Information
Table 86. Aurobindo Pharma Vaginal Anti Infectives Product Overview
Table 87. Aurobindo Pharma Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Aurobindo Pharma Business Overview
Table 89. Aurobindo Pharma Recent Developments
Table 90. AbbVie Inc Basic Information
Table 91. AbbVie Inc Vaginal Anti Infectives Product Overview
Table 92. AbbVie Inc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. AbbVie Inc Business Overview
Table 94. AbbVie Inc Recent Developments
Table 95. Melinta Therapeutics, Inc Basic Information
Table 96. Melinta Therapeutics, Inc Vaginal Anti Infectives Product Overview
Table 97. Melinta Therapeutics, Inc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Melinta Therapeutics, Inc Business Overview
Table 99. Melinta Therapeutics, Inc Recent Developments
Table 100. Bristol-Myers Squibb Company Basic Information
Table 101. Bristol-Myers Squibb Company Vaginal Anti Infectives Product Overview
Table 102. Bristol-Myers Squibb Company Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bristol-Myers Squibb Company Business Overview
Table 104. Bristol-Myers Squibb Company Recent Developments
Table 105. GSK plc Basic Information
Table 106. GSK plc Vaginal Anti Infectives Product Overview
Table 107. GSK plc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. GSK plc Business Overview
Table 109. GSK plc Recent Developments
Table 110. Bayer AG Basic Information
Table 111. Bayer AG Vaginal Anti Infectives Product Overview
Table 112. Bayer AG Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Bayer AG Business Overview
Table 114. Bayer AG Recent Developments
Table 115. Lupin Basic Information
Table 116. Lupin Vaginal Anti Infectives Product Overview
Table 117. Lupin Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Lupin Business Overview
Table 119. Lupin Recent Developments
Table 120. Perrigo Company plc Basic Information
Table 121. Perrigo Company plc Vaginal Anti Infectives Product Overview
Table 122. Perrigo Company plc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Perrigo Company plc Business Overview
Table 124. Perrigo Company plc Recent Developments
Table 125. Bayer Basic Information
Table 126. Bayer Vaginal Anti Infectives Product Overview
Table 127. Bayer Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Bayer Business Overview
Table 129. Bayer Recent Developments
Table 130. Sanofi Basic Information
Table 131. Sanofi Vaginal Anti Infectives Product Overview
Table 132. Sanofi Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Sanofi Business Overview
Table 134. Sanofi Recent Developments
Table 135. Scynexis Basic Information
Table 136. Scynexis Vaginal Anti Infectives Product Overview
Table 137. Scynexis Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Scynexis Business Overview
Table 139. Scynexis Recent Developments
Table 140. Bausch Health Companies Inc Basic Information
Table 141. Bausch Health Companies Inc Vaginal Anti Infectives Product Overview
Table 142. Bausch Health Companies Inc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Bausch Health Companies Inc Business Overview
Table 144. Bausch Health Companies Inc Recent Developments
Table 145. Global Vaginal Anti Infectives Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Vaginal Anti Infectives Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Vaginal Anti Infectives Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Vaginal Anti Infectives Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Vaginal Anti Infectives Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Vaginal Anti Infectives Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Vaginal Anti Infectives Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Vaginal Anti Infectives Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Vaginal Anti Infectives Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Vaginal Anti Infectives Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Vaginal Anti Infectives Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Vaginal Anti Infectives Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Vaginal Anti Infectives Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Vaginal Anti Infectives Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Vaginal Anti Infectives Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Vaginal Anti Infectives Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Vaginal Anti Infectives Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Vaginal Anti Infectives Market Size by Type (M USD)
Table 4. Global Vaginal Anti Infectives Market Size by Application
Table 5. Vaginal Anti Infectives Market Size Comparison by Region (M USD)
Table 6. Global Vaginal Anti Infectives Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Vaginal Anti Infectives Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Vaginal Anti Infectives Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Vaginal Anti Infectives Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Anti Infectives as of 2025)
Table 11. Global Market Vaginal Anti Infectives Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Vaginal Anti Infectives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Vaginal Anti Infectives Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Vaginal Anti Infectives Sales by Type (K MT)
Table 27. Global Vaginal Anti Infectives Market Size by Type (M USD)
Table 28. Global Vaginal Anti Infectives Sales (K MT) by Type (2020-2025)
Table 29. Global Vaginal Anti Infectives Sales Market Share by Type (2020-2025)
Table 30. Global Vaginal Anti Infectives Market Size (M USD) by Type (2020-2025)
Table 31. Global Vaginal Anti Infectives Market Share by Type (2020-2025)
Table 32. Global Vaginal Anti Infectives Price (USD/KG) by Type (2020-2025)
Table 33. Global Vaginal Anti Infectives Sales (K MT) by Application
Table 34. Global Vaginal Anti Infectives Market Size by Application
Table 35. Global Vaginal Anti Infectives Sales by Application (2020-2025) & (K MT)
Table 36. Global Vaginal Anti Infectives Sales Market Share by Application (2020-2025)
Table 37. Global Vaginal Anti Infectives Market Size by Application (2020-2025) & (M USD)
Table 38. Global Vaginal Anti Infectives Market Share by Application (2020-2025)
Table 39. Global Vaginal Anti Infectives Sales Growth Rate by Application (2020-2025)
Table 40. Global Vaginal Anti Infectives Sales by Region (2020-2025) & (K MT)
Table 41. Global Vaginal Anti Infectives Sales Market Share by Region (2020-2025)
Table 42. Global Vaginal Anti Infectives Market Size by Region (2020-2025) & (M USD)
Table 43. Global Vaginal Anti Infectives Market Size by Region (2020-2025)
Table 44. North America Vaginal Anti Infectives Sales by Country (2020-2025) & (K MT)
Table 45. North America Vaginal Anti Infectives Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Vaginal Anti Infectives Sales by Country (2020-2025) & (K MT)
Table 47. Europe Vaginal Anti Infectives Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Vaginal Anti Infectives Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Vaginal Anti Infectives Market Size by Region (2020-2025) & (M USD)
Table 50. South America Vaginal Anti Infectives Sales by Country (2020-2025) & (K MT)
Table 51. South America Vaginal Anti Infectives Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Vaginal Anti Infectives Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Vaginal Anti Infectives Market Size by Region (2020-2025) & (M USD)
Table 54. Global Vaginal Anti Infectives Production (K MT) by Region(2020-2025)
Table 55. Global Vaginal Anti Infectives Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Vaginal Anti Infectives Revenue Market Share by Region (2020-2025)
Table 57. Global Vaginal Anti Infectives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Vaginal Anti Infectives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Vaginal Anti Infectives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Vaginal Anti Infectives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Vaginal Anti Infectives Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Pfizer Inc Basic Information
Table 63. Pfizer Inc Vaginal Anti Infectives Product Overview
Table 64. Pfizer Inc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Pfizer Inc Business Overview
Table 66. Pfizer Inc SWOT Analysis
Table 67. Pfizer Inc Recent Developments
Table 68. Mylan N.V Basic Information
Table 69. Mylan N.V Vaginal Anti Infectives Product Overview
Table 70. Mylan N.V Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Mylan N.V Business Overview
Table 72. Mylan N.V SWOT Analysis
Table 73. Mylan N.V Recent Developments
Table 74. Novartis AG Basic Information
Table 75. Novartis AG Vaginal Anti Infectives Product Overview
Table 76. Novartis AG Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Novartis AG Business Overview
Table 78. Novartis AG SWOT Analysis
Table 79. Novartis AG Recent Developments
Table 80. Hikma Pharmaceuticals plc Basic Information
Table 81. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Overview
Table 82. Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Hikma Pharmaceuticals plc Business Overview
Table 84. Hikma Pharmaceuticals plc Recent Developments
Table 85. Aurobindo Pharma Basic Information
Table 86. Aurobindo Pharma Vaginal Anti Infectives Product Overview
Table 87. Aurobindo Pharma Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Aurobindo Pharma Business Overview
Table 89. Aurobindo Pharma Recent Developments
Table 90. AbbVie Inc Basic Information
Table 91. AbbVie Inc Vaginal Anti Infectives Product Overview
Table 92. AbbVie Inc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. AbbVie Inc Business Overview
Table 94. AbbVie Inc Recent Developments
Table 95. Melinta Therapeutics, Inc Basic Information
Table 96. Melinta Therapeutics, Inc Vaginal Anti Infectives Product Overview
Table 97. Melinta Therapeutics, Inc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Melinta Therapeutics, Inc Business Overview
Table 99. Melinta Therapeutics, Inc Recent Developments
Table 100. Bristol-Myers Squibb Company Basic Information
Table 101. Bristol-Myers Squibb Company Vaginal Anti Infectives Product Overview
Table 102. Bristol-Myers Squibb Company Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bristol-Myers Squibb Company Business Overview
Table 104. Bristol-Myers Squibb Company Recent Developments
Table 105. GSK plc Basic Information
Table 106. GSK plc Vaginal Anti Infectives Product Overview
Table 107. GSK plc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. GSK plc Business Overview
Table 109. GSK plc Recent Developments
Table 110. Bayer AG Basic Information
Table 111. Bayer AG Vaginal Anti Infectives Product Overview
Table 112. Bayer AG Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Bayer AG Business Overview
Table 114. Bayer AG Recent Developments
Table 115. Lupin Basic Information
Table 116. Lupin Vaginal Anti Infectives Product Overview
Table 117. Lupin Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Lupin Business Overview
Table 119. Lupin Recent Developments
Table 120. Perrigo Company plc Basic Information
Table 121. Perrigo Company plc Vaginal Anti Infectives Product Overview
Table 122. Perrigo Company plc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Perrigo Company plc Business Overview
Table 124. Perrigo Company plc Recent Developments
Table 125. Bayer Basic Information
Table 126. Bayer Vaginal Anti Infectives Product Overview
Table 127. Bayer Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Bayer Business Overview
Table 129. Bayer Recent Developments
Table 130. Sanofi Basic Information
Table 131. Sanofi Vaginal Anti Infectives Product Overview
Table 132. Sanofi Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Sanofi Business Overview
Table 134. Sanofi Recent Developments
Table 135. Scynexis Basic Information
Table 136. Scynexis Vaginal Anti Infectives Product Overview
Table 137. Scynexis Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Scynexis Business Overview
Table 139. Scynexis Recent Developments
Table 140. Bausch Health Companies Inc Basic Information
Table 141. Bausch Health Companies Inc Vaginal Anti Infectives Product Overview
Table 142. Bausch Health Companies Inc Vaginal Anti Infectives Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Bausch Health Companies Inc Business Overview
Table 144. Bausch Health Companies Inc Recent Developments
Table 145. Global Vaginal Anti Infectives Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Vaginal Anti Infectives Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Vaginal Anti Infectives Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Vaginal Anti Infectives Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Vaginal Anti Infectives Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Vaginal Anti Infectives Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Vaginal Anti Infectives Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Vaginal Anti Infectives Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Vaginal Anti Infectives Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Vaginal Anti Infectives Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Vaginal Anti Infectives Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Vaginal Anti Infectives Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Vaginal Anti Infectives Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Vaginal Anti Infectives Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Vaginal Anti Infectives Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Vaginal Anti Infectives Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Vaginal Anti Infectives Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Vaginal Anti Infectives
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaginal Anti Infectives Market Size (M USD), 2025-2035
Figure 5. Global Vaginal Anti Infectives Market Size (M USD) (2020-2035)
Figure 6. Global Vaginal Anti Infectives Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaginal Anti Infectives Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Vaginal Anti Infectives Product Life Cycle
Figure 13. Vaginal Anti Infectives Sales Share by Manufacturers in 2025
Figure 14. Global Vaginal Anti Infectives Revenue Share by Manufacturers in 2025
Figure 15. Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Vaginal Anti Infectives Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Vaginal Anti Infectives Revenue in 2025
Figure 18. Industry Chain Map of Vaginal Anti Infectives
Figure 19. Global Vaginal Anti Infectives Market PEST Analysis
Figure 20. Global Vaginal Anti Infectives Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Vaginal Anti Infectives Market Share by Type
Figure 27. Sales Market Share of Vaginal Anti Infectives by Type (2020-2025)
Figure 28. Sales Market Share of Vaginal Anti Infectives by Type in 2025
Figure 29. Market Share of Vaginal Anti Infectives by Type (2020-2025)
Figure 30. Market Share of Vaginal Anti Infectives by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Vaginal Anti Infectives Market Share by Application
Figure 33. Global Vaginal Anti Infectives Sales Market Share by Application (2020-2025)
Figure 34. Global Vaginal Anti Infectives Sales Market Share by Application in 2025
Figure 35. Global Vaginal Anti Infectives Market Share by Application (2020-2025)
Figure 36. Global Vaginal Anti Infectives Market Share by Application in 2025
Figure 37. Global Vaginal Anti Infectives Sales Growth Rate by Application (2020-2025)
Figure 38. Global Vaginal Anti Infectives Sales Market Share by Region (2020-2025)
Figure 39. Global Vaginal Anti Infectives Market Size by Region (2020-2025)
Figure 40. North America Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Vaginal Anti Infectives Sales Market Share by Country in 2024
Figure 43. North America Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Vaginal Anti Infectives Market Size by Country in 2024
Figure 45. U.S. Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Vaginal Anti Infectives Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Vaginal Anti Infectives Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Vaginal Anti Infectives Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Vaginal Anti Infectives Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Vaginal Anti Infectives Sales Market Share by Country in 2024
Figure 53. Europe Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Vaginal Anti Infectives Market Size by Country in 2024
Figure 55. Germany Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Vaginal Anti Infectives Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Vaginal Anti Infectives Sales Market Share by Region in 2024
Figure 67. Asia Pacific Vaginal Anti Infectives Market Size by Region in 2024
Figure 68. China Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Vaginal Anti Infectives Sales and Growth Rate (K MT)
Figure 79. South America Vaginal Anti Infectives Sales Market Share by Country in 2024
Figure 80. South America Vaginal Anti Infectives Market Size and Growth Rate (M USD)
Figure 81. South America Vaginal Anti Infectives Market Size by Country in 2024
Figure 82. Brazil Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Vaginal Anti Infectives Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Vaginal Anti Infectives Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Vaginal Anti Infectives Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Vaginal Anti Infectives Market Size by Region in 2024
Figure 92. Saudi Arabia Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Vaginal Anti Infectives Production Market Share by Region (2020-2025)
Figure 103. North America Vaginal Anti Infectives Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Vaginal Anti Infectives Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Vaginal Anti Infectives Production (K MT) Growth Rate (2020-2025)
Figure 106. China Vaginal Anti Infectives Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Vaginal Anti Infectives Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Vaginal Anti Infectives Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Vaginal Anti Infectives Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Vaginal Anti Infectives Market Share Forecast by Type (2026-2035)
Figure 111. Global Vaginal Anti Infectives Sales Forecast by Application (2026-2035)
Figure 112. Global Vaginal Anti Infectives Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Vaginal Anti Infectives
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaginal Anti Infectives Market Size (M USD), 2025-2035
Figure 5. Global Vaginal Anti Infectives Market Size (M USD) (2020-2035)
Figure 6. Global Vaginal Anti Infectives Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaginal Anti Infectives Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Vaginal Anti Infectives Product Life Cycle
Figure 13. Vaginal Anti Infectives Sales Share by Manufacturers in 2025
Figure 14. Global Vaginal Anti Infectives Revenue Share by Manufacturers in 2025
Figure 15. Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Vaginal Anti Infectives Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Vaginal Anti Infectives Revenue in 2025
Figure 18. Industry Chain Map of Vaginal Anti Infectives
Figure 19. Global Vaginal Anti Infectives Market PEST Analysis
Figure 20. Global Vaginal Anti Infectives Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Vaginal Anti Infectives Market Share by Type
Figure 27. Sales Market Share of Vaginal Anti Infectives by Type (2020-2025)
Figure 28. Sales Market Share of Vaginal Anti Infectives by Type in 2025
Figure 29. Market Share of Vaginal Anti Infectives by Type (2020-2025)
Figure 30. Market Share of Vaginal Anti Infectives by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Vaginal Anti Infectives Market Share by Application
Figure 33. Global Vaginal Anti Infectives Sales Market Share by Application (2020-2025)
Figure 34. Global Vaginal Anti Infectives Sales Market Share by Application in 2025
Figure 35. Global Vaginal Anti Infectives Market Share by Application (2020-2025)
Figure 36. Global Vaginal Anti Infectives Market Share by Application in 2025
Figure 37. Global Vaginal Anti Infectives Sales Growth Rate by Application (2020-2025)
Figure 38. Global Vaginal Anti Infectives Sales Market Share by Region (2020-2025)
Figure 39. Global Vaginal Anti Infectives Market Size by Region (2020-2025)
Figure 40. North America Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Vaginal Anti Infectives Sales Market Share by Country in 2024
Figure 43. North America Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Vaginal Anti Infectives Market Size by Country in 2024
Figure 45. U.S. Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Vaginal Anti Infectives Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Vaginal Anti Infectives Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Vaginal Anti Infectives Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Vaginal Anti Infectives Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Vaginal Anti Infectives Sales Market Share by Country in 2024
Figure 53. Europe Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Vaginal Anti Infectives Market Size by Country in 2024
Figure 55. Germany Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Vaginal Anti Infectives Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Vaginal Anti Infectives Sales Market Share by Region in 2024
Figure 67. Asia Pacific Vaginal Anti Infectives Market Size by Region in 2024
Figure 68. China Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Vaginal Anti Infectives Sales and Growth Rate (K MT)
Figure 79. South America Vaginal Anti Infectives Sales Market Share by Country in 2024
Figure 80. South America Vaginal Anti Infectives Market Size and Growth Rate (M USD)
Figure 81. South America Vaginal Anti Infectives Market Size by Country in 2024
Figure 82. Brazil Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Vaginal Anti Infectives Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Vaginal Anti Infectives Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Vaginal Anti Infectives Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Vaginal Anti Infectives Market Size by Region in 2024
Figure 92. Saudi Arabia Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Vaginal Anti Infectives Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Vaginal Anti Infectives Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Vaginal Anti Infectives Production Market Share by Region (2020-2025)
Figure 103. North America Vaginal Anti Infectives Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Vaginal Anti Infectives Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Vaginal Anti Infectives Production (K MT) Growth Rate (2020-2025)
Figure 106. China Vaginal Anti Infectives Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Vaginal Anti Infectives Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Vaginal Anti Infectives Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Vaginal Anti Infectives Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Vaginal Anti Infectives Market Share Forecast by Type (2026-2035)
Figure 111. Global Vaginal Anti Infectives Sales Forecast by Application (2026-2035)
Figure 112. Global Vaginal Anti Infectives Market Share Forecast by Application (2026-2035)
